1. Male or Female. 2. Aged 18 and older. 3. Have either T1DM or T2DM. 4. Hospitalised with suspected or confirmed novel coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)) infection at time of enrolment, categorised as stage 3, 4 or 5 on the WHO Ordinal Scale for Clinical Improvement. 5. Blood glucose level at or above 4 mmol/L. 6. Able to take oral (tablet) formulation of medication. 7. Patient is able to provide written informed consent prior to initiation of any study procedures.

1. Male or Female. 2. Aged 18 and older. 3. Have either T1DM or T2DM. 4. Hospitalised with suspected or confirmed novel coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)) infection at time of enrolment, categorised as stage 3, 4 or 5 on the WHO Ordinal Scale for Clinical Improvement. 5. Blood glucose level at or above 4 mmol/L. 6. Able to take oral (tablet) formulation of medication. 7. Patient is able to provide written informed consent prior to initiation of any study procedures.